Issue

Digital health is progressing at an astounding speed, aided by artificial intelligence (AI) technologies. Clinical labs and other healthcare providers face the ongoing challenge of understanding, navigating, and using these tools judiciously, with an eye toward protecting patients and avoiding liability.

After several decades of trial and error, researchers for the first time demonstrated that immune therapy could slow the onset of type 1 diabetes in individuals at risk for this chronic condition.

Whether you’re a first-time attendee or veteran of the AACC Annual Scientific Meeting & Clinical Lab Expo, AACC Artery offers plenty of opportunities to gear up for the 71st conclave in Anaheim, California.

Infectious disease testing often boils down to location, location, location: An appropriate testing venue for hepatitis may not work for influenza or a sexually transmitted infection. Tackling Infectious Disease Testing and Interpretation: Considering the Perspectives of the Core Clinical Laboratory and Point of Care Testing (34218) will explore options for…

The subject of ethics has not been explored extensively by the clinical laboratory community, but a scientific session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California, Ethical Issues in Laboratory Medicine (32101), plans to start a conversation on this topic. The speakers will present…

Confusion over the patenting of laboratory diagnostics in wake of recent court decisions has curtailed enthusiasm for private investment in these technologies. A scientific session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, Intellectual Property and Landmark Patent Lawsuits: The Role of U.S. Patents for Clinical Laboratory…

More than 800 exhibitors will be showcasing their innovations and technology at the 71th AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. For Jason Park MD, PhD, DABCC, chair of the Annual Meeting Organizing Committee, it’s an experience that calls for multiple trips.

Clinical labs play a multifaceted role in combating the opioid epidemic. If toxicology testing is the most visible part, an equally important service labs perform involves consulting with physicians to make sure they understand the most effective testing algorithms.

A meta-analysis of studies examining testing algorithms for Clostridioides difficile infection (CDI) recommended nucleic amplification tests (NAAT) as a best practice in three key clinical scenarios, either alone or in combination with other testing modalities, for identifying the C. difficile organism or toxin.

Individuals with HIV have a significantly higher risk of cardiovascular disease (CVD), but clinicians haven’t always understood this connection. In a new scientific statement, the American Heart Association (AHA) offers some causal explanations for the HIV/CVD relationship and proposes a pragmatic approach to assessing risk for and preventing atherosclerotic CVD…

Researchers and clinicians alike have placed stock in procalcitonin (PCT) testing for differentiating between infectious and noninfectious disease and for stratifying morbidity and mortality risk. However, more evidence about the limitations of this biomarker has become available, prompting three researchers to discuss in a review PCT’s role in the work-up…